[1]
Karmawan, Z.N.P., Simorangkir, R.L.Y. and Kalalo, J.G.K. 2025. Dapagliflozin in Heart Failure with Reduced Ejection Fraction (HFrEF): A Systematic Review of Its Mechanisms and Clinical Effectiveness. Journal of Pharmaceutical and Sciences. 8, 4 (Oct. 2025), 2339–2347. DOI:https://doi.org/10.36490/journal-jps.com.v8i4.1121.